Total Payments
$14,639
2024 Payments
$2,076
Companies
50
Transactions
1,015
Medicare Patients
977
Medicare Billing
$127,798
Payment Breakdown by Category
Food & Beverage$14,607 (99.8%)
Education$32.20 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,607 | 1,008 | 99.8% |
| Education | $32.20 | 7 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,079 | 118 | $0 (2024) |
| PFIZER INC. | $1,748 | 134 | $0 (2024) |
| Novo Nordisk Inc | $1,245 | 76 | $0 (2024) |
| ABBVIE INC. | $1,042 | 59 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,027 | 80 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,005 | 77 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $829.31 | 71 | $0 (2024) |
| Lilly USA, LLC | $828.87 | 73 | $0 (2024) |
| Amgen Inc. | $684.08 | 43 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $551.20 | 34 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,076 | 117 | PFIZER INC. ($503.36) |
| 2023 | $1,620 | 94 | PFIZER INC. ($290.35) |
| 2022 | $726.85 | 40 | ABBVIE INC. ($196.65) |
| 2021 | $1,250 | 85 | Boehringer Ingelheim Pharmaceuticals, Inc. ($206.00) |
| 2020 | $1,035 | 71 | AstraZeneca Pharmaceuticals LP ($196.15) |
| 2019 | $2,454 | 187 | AstraZeneca Pharmaceuticals LP ($285.97) |
| 2018 | $2,883 | 218 | AstraZeneca Pharmaceuticals LP ($404.34) |
| 2017 | $2,594 | 203 | Novo Nordisk Inc ($352.65) |
All Payment Transactions
1,015 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $29.75 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.33 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: PAIN | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/05/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Neuroscience | ||||||
| 12/03/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.01 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Cardio-renal | ||||||
| 11/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/14/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Diabetes Care | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Oncology | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: PSYCHIATRY | ||||||
| 10/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Cardio-renal | ||||||
| 10/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: PAIN | ||||||
| 10/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 111 | 1,329 | $60,302 | $23,340 |
| 2022 | 6 | 124 | 1,228 | $57,211 | $20,232 |
| 2021 | 8 | 289 | 2,088 | $90,647 | $33,589 |
| 2020 | 11 | 453 | 2,540 | $183,749 | $50,637 |
Total Patients
977
Total Services
7,185
Medicare Billing
$127,798
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 14 | 1,200 | $51,600 | $20,890 | 40.5% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 13 | 30 | $2,520 | $846.16 | 33.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 13 | 15 | $1,665 | $576.45 | 34.6% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 28 | 33 | $2,046 | $373.95 | 18.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 19 | 25 | $1,275 | $249.12 | 19.5% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 13 | 13 | $585.00 | $223.44 | 38.2% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 11 | 13 | $611.00 | $180.90 | 29.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 15 | 1,080 | $46,440 | $17,031 | 36.7% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2022 | 18 | 41 | $3,444 | $1,208 | 35.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 21 | 25 | $2,775 | $982.35 | 35.4% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 31 | 35 | $2,170 | $448.49 | 20.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 24 | 32 | $1,632 | $308.96 | 18.9% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2022 | 15 | 15 | $750.00 | $252.11 | 33.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 22 | 1,740 | $74,820 | $28,335 | 37.9% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 154 | 154 | $5,852 | $2,422 | 41.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 22 | 28 | $3,108 | $1,108 | 35.6% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2021 | 17 | 28 | $2,352 | $796.90 | 33.9% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 35 | 54 | $2,754 | $573.52 | 20.8% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 13 | 13 | $806.00 | $168.30 | 20.9% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2021 | 11 | 11 | $715.00 | $133.36 | 18.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 15 | 60 | $240.00 | $51.82 | 21.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2020 | 22 | 1,800 | $77,400 | $27,340 | 35.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 152 | 278 | $62,272 | $11,186 | 18.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 32 | 32 | $7,712 | $3,468 | 45.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 80 | 127 | $19,346 | $3,329 | 17.2% |
About Dr. Andrew Sperling, D.O
Dr. Andrew Sperling, D.O is a Family Medicine healthcare provider based in Claremore, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/28/2009. The National Provider Identifier (NPI) number assigned to this provider is 1932347929.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Sperling, D.O has received a total of $14,639 in payments from pharmaceutical and medical device companies, with $2,076 received in 2024. These payments were reported across 1,015 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($14,607).
As a Medicare-enrolled provider, Sperling has provided services to 977 Medicare beneficiaries, totaling 7,185 services with total Medicare billing of $127,798. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Claremore, OK
- Active Since 01/28/2009
- Last Updated 09/15/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1932347929
Products in Payments
- FARXIGA (Drug) $1,461
- TRELEGY ELLIPTA (Drug) $672.67
- XARELTO (Drug) $622.09
- JARDIANCE (Drug) $551.16
- Ozempic (Drug) $506.10
- ELIQUIS (Drug) $495.34
- VRAYLAR (Drug) $468.96
- TRULICITY (Drug) $464.31
- UBRELVY (Drug) $452.91
- Victoza (Drug) $387.29
- CHANTIX (Drug) $378.33
- NURTEC ODT (Drug) $345.22
- TRINTELLIX (Drug) $334.02
- JANUVIA (Drug) $313.84
- STIOLTO RESPIMAT (Drug) $281.11
- QULIPTA (Drug) $278.41
- SYMBICORT (Drug) $256.99
- Aimovig (Biological) $245.20
- SOLIQUA (Drug) $240.69
- AIRSUPRA (Drug) $220.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Claremore
Dr. Brent Hinkle, D.o, D.O
Family Medicine — Payments: $15,112
Family Medicine $15,112
Dr. Seth Nodine, Md, MD
Family Medicine — Payments: $14,679
Family Medicine $14,679
Dr. Jeffrey Williams, D.o, D.O
Family Medicine — Payments: $13,050
Family Medicine $13,050
Christen Greuel, D.o, D.O
Family Medicine — Payments: $6,854
Family Medicine $6,854
Ashley Bridges
Family Medicine — Payments: $5,694
Family Medicine $5,694
Dwight Korgan, M.d, M.D
Family Medicine — Payments: $2,358
Family Medicine $2,358